Search

Codexis Inc

Cerrado

SectorSanidad

0.99 -10

Resumen

Variación precio

24h

Actual

Mínimo

0.99

Máximo

1.11

Métricas clave

By Trading Economics

Ingresos

-3.3M

-12M

Ventas

-333K

15M

BPA

-0.13

Margen de beneficios

-80.489

Empleados

146

EBITDA

-3.4M

-9.8M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+501.85% upside

Dividendos

By Acuity

Próximas Ganancias

12 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-40M

122M

Apertura anterior

10.99

Cierre anterior

0.99

Codexis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 nov 2026, 21:01 UTC

News

Codexis, Inc. announced a $60 million loan agreement with Trinity Capital to refinance debt and advance its ECO Synthesis Manufacturing Platform for siRNA therapeutics.

9 nov 2026, 21:07 UTC

News

Codexis highlights advancements in its ECO Synthesis platform at TIDES Europe 2026, achieving over 90% product quality and reducing cycle time significantly.

6 nov 2026, 21:05 UTC

Macro Event

Codexis, Inc. shares are advancing sharply, supported by a rise in the Michigan Consumer Sentiment Index to 51.0, exceeding expectations.

5 nov 2026, 20:46 UTC

Codexis, Inc. shares fell sharply, retracing significantly since Wednesday's close and remaining near the lower end of their one-month range.

4 nov 2026, 21:07 UTC

Codexis, Inc. is trading roughly flat, maintaining a position near unchanged since Tuesday's close, despite earlier reaching a high of 3.70%.

3 nov 2026, 20:51 UTC

Codexis, Inc. is trading higher, recovering from a low point yesterday and maintaining a positive return since Monday's close.

2 nov 2026, 21:05 UTC

Codexis, Inc. shares fell sharply, reversing an initial gain to reach a session low, continuing a broader downward trend over the past month.

29 oct 2026, 20:02 UTC

News

Codexis, Inc. will report its third-quarter 2026 financial results on November 12, 2026, after market close, with a conference call at 4:30 PM ET.

28 oct 2026, 20:01 UTC

Codexis, Inc. shares are rising during Wednesday's trading session, gaining ground since Tuesday's close.

27 oct 2026, 20:07 UTC

Codexis, Inc. shares are declining, moving lower from Monday's close and significantly below their 20-day moving average.

23 oct 2026, 19:26 UTC

Codexis Inc shares fell significantly, remaining well below their 20-day moving average amid a challenging backdrop for the life sciences sector.

22 oct 2026, 20:07 UTC

Codexis Inc shares are advancing, having peaked earlier in the day, though currently positioned below its 20-day moving average within its one-month trading range.

21 oct 2026, 20:07 UTC

Codexis Inc shares are advancing.

20 oct 2026, 20:01 UTC

Codexis Inc shares fell sharply, trading well below their 20-day moving average and near the lower end of their one-month trading range.

19 oct 2026, 20:01 UTC

Codexis Inc shares are trading sharply higher, reflecting strong performance as the stock remains in the middle of its one-month trading range.

16 oct 2026, 20:01 UTC

Codexis Inc shares fell sharply, continuing a decline since Thursday's close and trading significantly below its 20-day moving average.

15 oct 2026, 20:02 UTC

Codexis Inc shares are advancing, recovering from an early dip to finish notably higher, though still below the 20-day moving average.

14 oct 2026, 23:06 UTC

Codexis Inc is advancing in after-market trading, gaining ground since Wednesday's close, though it remains below its 20-day moving average.

13 oct 2026, 20:01 UTC

Codexis Inc shares fell sharply, breaking a streak of higher daily closes since Monday, diverging from recent upward momentum.

8 oct 2026, 19:24 UTC

Codexis Inc shares fell sharply, continuing a downward trend from Wednesday's close, reaching their lowest point shortly after the market opened.

7 oct 2026, 20:00 UTC

Codexis Inc is advancing in Wednesday's trading session, having previously peaked over 5% while remaining above its 20-day moving average.

5 oct 2026, 20:06 UTC

Codexis Inc is trading modestly higher, fluctuating around the midpoint of its one-month range after peaking in the early afternoon.

1 oct 2026, 20:01 UTC

Codexis Inc shares fell amid declines in the Life Sciences Tools & Services sub-sector, remaining below the 20-day moving average.

30 sept 2026, 20:01 UTC

Codexis Inc is advancing in Wednesday's market session, having peaked earlier before pulling back, but remains below its 20-day moving average.

25 sept 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a trend of lower performance amid broader market volatility and declines over the past three sessions.

24 sept 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a decline since Wednesday and closing below its 20-day moving average near the lower end of its one-month range.

23 sept 2026, 20:07 UTC

Codexis Inc shares fell as concerns about inflation and rising bond yields weighed on investor sentiment, pulling back after an earlier session rebound.

22 sept 2026, 20:01 UTC

Codexis Inc shares are up significantly in the current session, marking the third consecutive day of gains, despite remaining below the 20-day moving average.

18 sept 2026, 20:02 UTC

Codexis Inc is trading sharply higher, rebounding from three consecutive days of lower closes, though it remains below its 20-day moving average.

17 sept 2026, 20:01 UTC

Codexis Inc shares fell sharply, continuing a trend of three consecutive sessions lower, with the current price significantly below its 20-day moving average.

Comparación entre iguales

Cambio de precio

Codexis Inc previsión

Precio Objetivo

By TipRanks

501.85% repunte

Estimación a 12 Meses

Media 6.5 USD  501.85%

Máximo 11 USD

Mínimo 2 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Codexis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

4

Comprar

1

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
help-icon Live chat